ArticleInternal and emergency medicine2026
Non-invasive hemoglobin estimation with outcome prediction via deep learning analysis of ECG-derived cardiac micro-dynamics.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep Learning Applied to 12-Lead ECGs for Detection of Structural, Metabolic and Systemic Disease.Diagnostics (Basel, Switzerland) · 2026Review
- Bridging the gap from clinical to home ECG: quantifying and overcoming accuracy loss in AI-enabled single-lead ECG models.NPJ digital medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnemia is a global health issue, especially in resource-limited areas, where traditional hemoglobin (Hb) testing is invasive and costly. This study aimed to develop an electrocardiogram-hemoglobin (ECG-Hb) deep learning model (DLM) for detecting anemia and assess its impact on all-cause mortality and new-onset heart failure.
methodsThis retrospective study analyzed ECGs and corresponding Hb levels from two hospitals. The DLM was trained on 388,166 ECGs from 187,202 patients and tested on 24,279 and 29,247 patients in internal and external sets, respectively. Anemia was defined as moderate (Hb ≤ 10 g/dL) or severe (Hb ≤ 8 g/dL). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, and an 8-year follow-up assessed mortality and heart failure risk with Cox regression.
resultsThe areas under the ROC curves (AUCs) for detecting moderate-to-severe anemia were 0.8545 (internal) and 0.8243 (external), with sensitivities of 65.9% and 71.0%, and specificities of 84.8% and 77.4%, respectively. ECG-Hb performed better in detecting severe anemia (AUC = 0.9038/0.8766) than in mild anemia. Pearson correlations between ECG-Hb and Hb were 0.56 (internal) and 0.53 (external). Key ECG features, including heart rate variability, significantly influenced ECG-Hb. Patients with severely low ECG-Hb had higher risks of mortality (hazard ratio [HR]: 1.71, 95% confidence interval [CI]: 1.42-2.06) and heart failure (HR: 2.47, 95% CI: 2.07-2.94) compared to those with standard ECG-Hb levels.
conclusionThe ECG-Hb DLM offers strong diagnostic and prognostic potential for anemia and cardiovascular risks, making it a valuable, non-invasive screening tool in low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.